Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 403

1.

Immune gene expression in head and neck squamous cell carcinoma patients.

Lecerf C, Kamal M, Vacher S, Chemlali W, Schnitzler A, Morel C, Dubot C, Jeannot E, Meseure D, Klijanienko J, Mariani O, Borcoman E, Calugaru V, Badois N, Chilles A, Lesnik M, Krhili S, Choussy O, Hoffmann C, Piaggio E, Bieche I, Le Tourneau C.

Eur J Cancer. 2019 Oct 5;121:210-223. doi: 10.1016/j.ejca.2019.08.028. [Epub ahead of print]

PMID:
31593831
2.

Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model.

Park S, Zhu J, Altan-Bonnet G, Cheng SY.

Am J Cancer Res. 2019 Jul 1;9(7):1439-1453. eCollection 2019.

3.

Tumor intrinsic immunity related proteins may be novel tumor suppressors in some types of cancer.

Xiong D, Wang Y, You M.

Sci Rep. 2019 Jul 29;9(1):10918. doi: 10.1038/s41598-019-47382-3.

4.

Immune signature profiling identified prognostic factors for gastric cancer.

Yang W, Lai Z, Li Y, Mu J, Yang M, Xie J, Xu J.

Chin J Cancer Res. 2019 Jun;31(3):463-470. doi: 10.21147/j.issn.1000-9604.2019.03.08.

5.

HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality.

Richards DM, Marschall V, Billian-Frey K, Heinonen K, Merz C, Redondo Müller M, Sefrin JP, Schröder M, Sykora J, Fricke H, Hill O, Gieffers C, Thiemann M.

J Immunother Cancer. 2019 Jul 19;7(1):191. doi: 10.1186/s40425-019-0671-4.

6.

Gene expression profile of human T cells following a single stimulation of peripheral blood mononuclear cells with anti-CD3 antibodies.

Sousa IG, Simi KCR, do Almo MM, Bezerra MAG, Doose G, Raiol T, Stadler PF, Hoffmann S, Maranhão AQ, Brigido MM.

BMC Genomics. 2019 Jul 19;20(1):593. doi: 10.1186/s12864-019-5967-8.

7.

The transcription factor NFIL3 controls regulatory T-cell function and stability.

Kim HS, Sohn H, Jang SW, Lee GR.

Exp Mol Med. 2019 Jul 16;51(7):80. doi: 10.1038/s12276-019-0280-9.

PMID:
31311918
8.

Transcriptional analysis of host responses related to immunity in chicken spleen tissues infected with reticuloendotheliosis virus strain SNV.

Gao S, Wang Z, Jiang H, Sun J, Diao Y, Tang Y, Hu J.

Infect Genet Evol. 2019 Oct;74:103932. doi: 10.1016/j.meegid.2019.103932. Epub 2019 Jun 20.

PMID:
31228642
9.

Rational design of anti-GITR-based combination immunotherapy.

Zappasodi R, Sirard C, Li Y, Budhu S, Abu-Akeel M, Liu C, Yang X, Zhong H, Newman W, Qi J, Wong P, Schaer D, Koon H, Velcheti V, Hellmann MD, Postow MA, Callahan MK, Wolchok JD, Merghoub T.

Nat Med. 2019 May;25(5):759-766. doi: 10.1038/s41591-019-0420-8. Epub 2019 Apr 29.

PMID:
31036879
10.

Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT.

Noviello M, Manfredi F, Ruggiero E, Perini T, Oliveira G, Cortesi F, De Simone P, Toffalori C, Gambacorta V, Greco R, Peccatori J, Casucci M, Casorati G, Dellabona P, Onozawa M, Teshima T, Griffioen M, Halkes CJM, Falkenburg JHF, Stölzel F, Altmann H, Bornhäuser M, Waterhouse M, Zeiser R, Finke J, Cieri N, Bondanza A, Vago L, Ciceri F, Bonini C.

Nat Commun. 2019 Mar 25;10(1):1065. doi: 10.1038/s41467-019-08871-1.

11.

Costimulation of type-2 innate lymphoid cells by GITR promotes effector function and ameliorates type 2 diabetes.

Galle-Treger L, Sankaranarayanan I, Hurrell BP, Howard E, Lo R, Maazi H, Lewis G, Banie H, Epstein AL, Hu P, Rehan VK, Gilliland FD, Allayee H, Soroosh P, Sharpe AH, Akbari O.

Nat Commun. 2019 Feb 12;10(1):713. doi: 10.1038/s41467-019-08449-x.

12.

GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma.

van Beek AA, Zhou G, Doukas M, Boor PPC, Noordam L, Mancham S, Campos Carrascosa L, van der Heide-Mulder M, Polak WG, Ijzermans JNM, Pan Q, Heirman C, Mahne A, Bucktrout SL, Bruno MJ, Sprengers D, Kwekkeboom J.

Int J Cancer. 2019 Aug 15;145(4):1111-1124. doi: 10.1002/ijc.32181. Epub 2019 Feb 27.

13.

CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapy.

Chen S, Fan J, Zhang M, Qin L, Dominguez D, Long A, Wang G, Ma R, Li H, Zhang Y, Fang D, Sosman J, Zhang B.

Nat Commun. 2019 Jan 11;10(1):150. doi: 10.1038/s41467-018-08123-8.

14.

Pre-immunization of donor lymphocytes with GITR agonistic antibody enhances antitumor immunity in autologous hematopoietic stem cell transplantation.

Henmi M, Shibasaki C, Mizoguchi Y, Hirata A, Sawai E, Narumi K, Aoki K.

Biochem Biophys Res Commun. 2019 Jan 29;509(1):96-101. doi: 10.1016/j.bbrc.2018.12.069. Epub 2018 Dec 20.

15.

GITRL on inflammatory antigen presenting cells in the lung parenchyma provides signal 4 for T-cell accumulation and tissue-resident memory T-cell formation.

Chu KL, Batista NV, Wang KC, Zhou AC, Watts TH.

Mucosal Immunol. 2019 Mar;12(2):363-377. doi: 10.1038/s41385-018-0105-5. Epub 2018 Nov 28.

PMID:
30487647
16.

Overexpression of Regulatory T Cell-Related Markers (FOXP3, CTLA-4 and GITR) by Peripheral Blood Mononuclear Cells from Patients with Breast Cancer

Khalife E, Khodadadi A, Talaeizadeh A, Rahimian L, Nemati M, Jafarzadeh A.

Asian Pac J Cancer Prev. 2018 Nov 28;19(11):3019-3025.

17.

Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8+ T cell dysfunction and maintain memory phenotype.

Wang B, Zhang W, Jankovic V, Golubov J, Poon P, Oswald EM, Gurer C, Wei J, Ramos I, Wu Q, Waite J, Ni M, Adler C, Wei Y, Macdonald L, Rowlands T, Brydges S, Siao J, Poueymirou W, MacDonald D, Yancopoulos GD, Sleeman MA, Murphy AJ, Skokos D.

Sci Immunol. 2018 Nov 2;3(29). pii: eaat7061. doi: 10.1126/sciimmunol.aat7061.

PMID:
30389797
18.

Identification of a six-gene signature with prognostic value for patients with endometrial carcinoma.

Wang Y, Ren F, Chen P, Liu S, Song Z, Ma X.

Cancer Med. 2018 Nov;7(11):5632-5642. doi: 10.1002/cam4.1806. Epub 2018 Oct 10.

19.

Tolerogenic dendritic cells induced the enrichment of CD4+Foxp3+ regulatory T cells via TGF-β in mesenteric lymph nodes of murine LPS-induced tolerance model.

Jia L, Lu J, Zhou Y, Tao Y, Xu H, Zheng W, Zhao J, Liang G, Xu L.

Clin Immunol. 2018 Dec;197:118-129. doi: 10.1016/j.clim.2018.09.010. Epub 2018 Sep 21.

PMID:
30248398
20.

Enhancing immunotherapy of STING agonist for lymphoma in preclinical models.

Sallets A, Robinson S, Kardosh A, Levy R.

Blood Adv. 2018 Sep 11;2(17):2230-2241. doi: 10.1182/bloodadvances.2018020040.

Supplemental Content

Loading ...
Support Center